换一批Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
第一作者：
A,Schneeweiss
第一单位：
National Center for Tumor Diseases, University Hospital, Heidelberg, Germany. schneeweiss@med.uni-heidelberg.de
作者：
医学主题词
蒽环类(Anthracyclines);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡铂(Carboplatin);环磷酰胺(Cyclophosphamide);表柔比星(Epirubicin);女(雌)性(Female);氟尿嘧啶(Fluorouracil);心脏(Heart);人类(Humans);炎性乳腺肿瘤(Inflammatory Breast Neoplasms);肿瘤辅助疗法(Neoadjuvant Therapy);每搏输出量(Stroke Volume);紫杉烷类(Taxoids);心室功能, 左(Ventricular Function, Left)
DOI
10.1093/annonc/mdt182
PMID
23704196
发布时间
2022-04-09
- 浏览458
Annals of oncology
2278-84页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
